Today: 21 May 2026
Vistra stock jumps after Meta signs 20-year nuclear power deal to feed AI data centers

Vistra stock jumps after Meta signs 20-year nuclear power deal to feed AI data centers

NEW YORK, Jan 9, 2026, 17:13 EST — After-hours

  • Vistra shares rose about 10.5% after-hours after Meta announced 20-year nuclear power agreements tied to three Vistra plants
  • Vistra says the contracts cover more than 2,600 MW from Perry, Davis-Besse and Beaver Valley in PJM, with deliveries starting in late 2026
  • An SEC filing outlines spending for plant “uprates” through 2034 and projects a lift to Vistra’s cash generation

Vistra Corp (VST) shares rose 10.5% in after-hours trading on Friday after Meta Platforms said it struck 20-year agreements to buy power from three Vistra nuclear plants. Shares were at $166.37 after swinging between $150.83 and $178.40 earlier in the day. Meta also said it will work with Oklo and TerraPower on small modular reactors, or SMRs — smaller nuclear units meant to be built largely in factories.

The deal lands as tech companies hunt for steady electricity to run data centers, where “always on” matters more than cheap power for a few hours. Nuclear fits that bill, and the market has treated long-dated power contracts as scarce assets as grid demand tightens.

For Vistra, a long-term buyer can blunt the swings of wholesale power prices and make it easier to justify big checks for maintenance and upgrades. That is the basic trade in merchant power: take price risk, or sell it off when a deep-pocketed customer shows up.

Vistra said the contracts cover more than 2,600 megawatts of zero-carbon electricity from its Perry and Davis-Besse plants in Ohio and the Beaver Valley plant in Pennsylvania, in PJM Interconnection, the grid operator that runs power markets across parts of the Mid-Atlantic and Midwest. A power purchase agreement, or PPA, is a long-term contract to buy electricity at set terms; Vistra said Meta’s purchases begin in late 2026, with more output added through 2034 via “uprates” — equipment upgrades that boost a plant’s capacity. Vistra CEO Jim Burke said the commitment gives the company “the certainty needed to invest,” while Meta’s head of global energy, Urvi Parekh, called nuclear “clean, reliable power” for the company’s AI buildout. Vistra Corp. Investor Relations

A securities filing showed the PPAs cover 2,609 megawatts of energy and capacity — payments for being available to generate during peak demand — from Vistra’s PJM nuclear fleet. Vistra said it expects to start delivering a portion of the operating output in late 2026 and reach full delivery by the end of 2027; uprate-related capacity is slated to start in 2031 and ramp through year-end 2034, with capital spending beginning in 2026 and less than 20% of the total projected by end-2028. At full delivery, Vistra said the contracts should lift its adjusted free cash flow before growth — a company cash metric before new investment — by about 8% to 10% from operating output and another 5% to 7% once the uprates are fully online, based on its 2026 guidance.

Vistra also said the electricity will continue to flow into the PJM grid rather than being routed directly to Meta, framing the contracts as a financial backstop for output that still serves the wider market. That point matters in PJM, where capacity and reliability debates can turn political fast.

But the payoff depends on regulators and plant operators delivering those uprates on time and on budget, and on Meta’s long-term load forecasts holding up. Delays in permits, cost overruns, or a sharp shift in regional power prices could narrow the cash gains investors are now penciling in.

Traders will look for more detail on pricing and on the schedule for permits and outage work tied to the uprates, along with any update to Vistra’s 2026 cash-flow outlook. The first deliveries under the Meta contracts are slated for late 2026, with full operating output by year-end 2027 and the added uprate capacity scheduled to roll in through 2034.

Stock Market Today

  • SpaceX Set to Go Public: Key Details and Market Impact
    May 20, 2026, 8:02 PM EDT. SpaceX, founded by Elon Musk, is poised to go public, joining hundreds of companies that raised $70 billion in U.S. equity markets last year. Going public means the company will offer shares for sale on stock exchanges, allowing investors to buy ownership stakes. This move could unlock significant capital for SpaceX's ambitious space ventures, while providing early investors a chance to realize gains. The offering is closely watched amid a strong appetite for tech and aerospace stocks, reflecting broader market interest in innovation-driven firms.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Applied Digital stock jumps again as AI data-center demand and hyperscaler talks drive the tape
Previous Story

Applied Digital stock jumps again as AI data-center demand and hyperscaler talks drive the tape

Bank of America stock dips after-hours after $3 billion debt call, with earnings next week
Next Story

Bank of America stock dips after-hours after $3 billion debt call, with earnings next week

Go toTop